So-Young International (SY) EBITDA Margin (2018 - 2026)
So-Young International (SY) posted EBITDA Margin of 13.32% for Q1 2026, up 50.08% on a QoQ basis from 26.68% in Q4 2025, and up 128.0% year-over-year from 5.84% in Q1 2025.
So-Young International (SY) has 2 years of EBITDA Margin data on file, last reported at 13.32% in Q1 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 30.85 Bn | 24.28 Bn | 622.47 Mn | 29.00% |
| 2 | BrightSpring Health Services | 12.29 Bn | 11.41 Bn | 482.22 Mn | 3.36% |
| 3 | Healthequity | 7.80 Bn | 7.48 Bn | 256.31 Mn | 29.03% |
| 4 | Hinge Health | 4.82 Bn | 4.51 Bn | 154.23 Mn | 19.09% |
| 5 | Doximity | 4.21 Bn | 3.46 Bn | 125.97 Mn | 17.08% |
| 6 | Waystar Holding | 4.18 Bn | 4.03 Bn | 268.04 Mn | 27.87% |
| 7 | 10x Genomics | 3.78 Bn | 3.24 Bn | 106.18 Mn | -11.30% |
| 8 | Privia Health | 2.65 Bn | 2.28 Bn | 595.71 Mn | 1.25% |
| 9 | Omnicell | 1.95 Bn | 1.78 Bn | 140.36 Mn | 5.44% |
| 10 | So-Young International | 28.43 Mn | -78.18 Mn | 26.35 Mn | -13.32% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -13.32% |
| Dec 31, 2025 | -26.69% |
| Sep 30, 2025 | -18.70% |
| Jun 30, 2025 | -12.32% |
| Mar 31, 2025 | -14.58% |
| Dec 31, 2024 | -162.25% |
| Sep 30, 2024 | 1.26% |
| Jun 30, 2024 | 1.65% |
| Mar 31, 2024 | -11.69% |
| Dec 31, 2023 | -1.26% |
| Sep 30, 2023 | -0.52% |
| Jun 30, 2023 | -5.03% |
| Mar 31, 2023 | -10.78% |
| Dec 31, 2022 | 7.49% |
| Sep 30, 2022 | -2.27% |
| Jun 30, 2022 | -13.59% |
| Mar 31, 2022 | -25.89% |
| Dec 31, 2021 | -11.01% |
| Sep 30, 2021 | 4.45% |
| Jun 30, 2021 | 12.76% |
| Mar 31, 2021 | -16.88% |
| Dec 31, 2020 | 7.02% |
| Sep 30, 2020 | 8.41% |
| Jun 30, 2020 | -3.00% |
| Mar 31, 2020 | 25.42% |
| Dec 31, 2019 | 21.43% |
| Sep 30, 2019 | 31.07% |
| Jun 30, 2019 | 24.23% |
| Mar 31, 2019 | 14.43% |
| Dec 31, 2018 | 21.35% |
| Sep 30, 2018 | -0.81% |
| Jun 30, 2018 | 23.42% |
| Mar 31, 2018 | 14.23% |